BR112022019685A2 - Composições de ácido siálico para uso na inibição ou no tratamento de infecções por coronavírus - Google Patents
Composições de ácido siálico para uso na inibição ou no tratamento de infecções por coronavírusInfo
- Publication number
- BR112022019685A2 BR112022019685A2 BR112022019685A BR112022019685A BR112022019685A2 BR 112022019685 A2 BR112022019685 A2 BR 112022019685A2 BR 112022019685 A BR112022019685 A BR 112022019685A BR 112022019685 A BR112022019685 A BR 112022019685A BR 112022019685 A2 BR112022019685 A2 BR 112022019685A2
- Authority
- BR
- Brazil
- Prior art keywords
- sialic acid
- inhibition
- treatment
- virus infections
- corona virus
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063003477P | 2020-04-01 | 2020-04-01 | |
| PCT/IB2021/000200 WO2021198774A1 (en) | 2020-04-01 | 2021-03-31 | Sialic acid compositions for use in inhibiting and treating coronavirus infection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112022019685A2 true BR112022019685A2 (pt) | 2022-11-22 |
Family
ID=76250375
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112022019685A BR112022019685A2 (pt) | 2020-04-01 | 2021-03-31 | Composições de ácido siálico para uso na inibição ou no tratamento de infecções por coronavírus |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US11813271B2 (https=) |
| EP (1) | EP4125926A1 (https=) |
| JP (1) | JP2023520703A (https=) |
| KR (1) | KR20220161413A (https=) |
| CN (1) | CN115461057A (https=) |
| AU (1) | AU2021247584B2 (https=) |
| BR (1) | BR112022019685A2 (https=) |
| CA (1) | CA3173633A1 (https=) |
| WO (1) | WO2021198774A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230226088A1 (en) * | 2020-06-09 | 2023-07-20 | The Texas A&M University System | Therapeutics for treatment of covid-19 symptoms |
| WO2023104402A1 (en) | 2021-12-09 | 2023-06-15 | Frieslandcampina Nederland B.V. | Milk fraction that inhibits covid-19 infection |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5976573A (en) | 1996-07-03 | 1999-11-02 | Rorer Pharmaceutical Products Inc. | Aqueous-based pharmaceutical composition |
| EP2364139A2 (en) * | 2008-11-10 | 2011-09-14 | Life Science Nutrition AS | Ngna compositions and methods of use |
| AU2010315024B2 (en) * | 2009-11-06 | 2015-02-12 | Nexbio, Inc. | Methods, compounds and compositions for treatment and prophylaxis in the respiratory tract |
| CN111787925A (zh) * | 2017-10-11 | 2020-10-16 | 生命科学股份有限公司 | N-乙酰神经氨酸组合物和使用方法 |
| CN111481560A (zh) * | 2020-04-23 | 2020-08-04 | 菌维他(北京)医疗科技有限公司 | 唾液酸及衍生物在制备防治冠状病毒疾病的药品中的应用 |
| CN111658631A (zh) | 2020-06-11 | 2020-09-15 | 广东盛普生命科技有限公司 | 没食子酸及其衍生物和结构类似物在制备抗冠状病毒药物方面的应用 |
-
2021
- 2021-03-31 AU AU2021247584A patent/AU2021247584B2/en active Active
- 2021-03-31 CA CA3173633A patent/CA3173633A1/en active Pending
- 2021-03-31 US US17/916,104 patent/US11813271B2/en active Active
- 2021-03-31 WO PCT/IB2021/000200 patent/WO2021198774A1/en not_active Ceased
- 2021-03-31 CN CN202180027387.8A patent/CN115461057A/zh active Pending
- 2021-03-31 JP JP2022560329A patent/JP2023520703A/ja active Pending
- 2021-03-31 KR KR1020227037491A patent/KR20220161413A/ko active Pending
- 2021-03-31 EP EP21729616.9A patent/EP4125926A1/en active Pending
- 2021-03-31 BR BR112022019685A patent/BR112022019685A2/pt unknown
-
2023
- 2023-11-13 US US18/389,006 patent/US12390481B2/en active Active
-
2025
- 2025-08-18 US US19/302,949 patent/US20260083762A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20260083762A1 (en) | 2026-03-26 |
| US20240148763A1 (en) | 2024-05-09 |
| KR20220161413A (ko) | 2022-12-06 |
| JP2023520703A (ja) | 2023-05-18 |
| WO2021198774A1 (en) | 2021-10-07 |
| AU2021247584A1 (en) | 2022-10-20 |
| CA3173633A1 (en) | 2021-10-07 |
| EP4125926A1 (en) | 2023-02-08 |
| CN115461057A (zh) | 2022-12-09 |
| US11813271B2 (en) | 2023-11-14 |
| US12390481B2 (en) | 2025-08-19 |
| US20230128687A1 (en) | 2023-04-27 |
| AU2021247584B2 (en) | 2023-11-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112022016413A2 (pt) | Método para o tratamento ou prevenção do coronavírus causado pelo vírus coronavírus da síndrome respiratória aguda grave 2, composto, e, uso de um composto | |
| BR112022026321A2 (pt) | Análogos de 1'-ciano nucleosídeo e usos dos mesmos | |
| PH12022552794A1 (en) | Antiviral application of nucleoside analog or combination formulation containing nucleoside analog | |
| BR112021022624A2 (pt) | Compostos para o tratamento da doença de huntington | |
| BR112022023013A2 (pt) | Inibidores de mek para tratamento ou prevenção de infecções por coronavírus e/ou de tempestade de citocinas de covid-19 | |
| BR112023002951A2 (pt) | Compostos de fosfolipídio e usos destes | |
| BR112023025358A2 (pt) | Inibidores de protease como antivirais | |
| BR112022025037A2 (pt) | Compostos antivirais para tratar infecções por coronavírus, picornavírus e norovírus | |
| BR112022000503A2 (pt) | Compostos úteis para tratar infecções por vírus influenza | |
| BR112022026899A2 (pt) | Composto representado pela fórmula (i) ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, método de tratamento ou prevenção de uma infecção por vírus, método de inibição da protease 3c viral ou protease 3cl viral em um mamífero e método de tratamento de um distúrbio respiratório | |
| BR112022021962A2 (pt) | Imidazopiridazinas como moduladores de il-17 | |
| MX2021014742A (es) | Peptidomimeticos para el tratamiento de infecciones por coronavirus y picornavirus. | |
| BR112013032711A2 (pt) | composições farmacêuticas compreendendo sulbactam e inibidor de beta-lactamase | |
| BR112021022758A2 (pt) | Compostos de 1-oxo-isoindolina-5-carboxamida substituídos, suas composições e métodos de tratamento com os mesmos | |
| CO2020004087A2 (es) | Compuestos monobactámicos cromanos para el tratamiento de infecciones bacterianas | |
| BR0206266A (pt) | Heterocìclicos de difenila substituìda útil para tratar infecção por hcv | |
| BR112022020147A2 (pt) | Compostos para tratar a doença de huntington | |
| BR112022017243A2 (pt) | Lactoferrina para uso oral com ação antiviral | |
| BR112022013480A2 (pt) | Métodos de tratamento de coronavírus | |
| BR112018072339A2 (pt) | tratamento de distúrbios de perda de cabelo com inibidores de jak deuterados | |
| BR112022019685A2 (pt) | Composições de ácido siálico para uso na inibição ou no tratamento de infecções por coronavírus | |
| MX2022009176A (es) | Metodo y composiciones para el tratamiento de infeccion por coronavirus. | |
| BR112019024549A2 (pt) | compostos derivados de glicopeptídeo e usos dos mesmos | |
| BR112021020605A2 (pt) | Inibidor de mek para o tratamento de infecções virais e bacterianas | |
| UY39313A (es) | Composiciones amortiguadoras para el tratamiento de infecciones virales transmitidas por el aire |